When Sens. Richard Blumenthal and Elizabeth Warren surveyed the nation’s pharmacies they found most of them failed to stock Lispro, a lower-cost insulin.
The most controversial section of the bill would direct the secretary of the Department of Health and Human Services to directly negotiate with drugmakers on the price of medications covered under Medicare.
The state House of Representatives unanimously approved a comprehensive bill that aims to shed light on the murky prescription drug industry, which state officials say is a necessary first step to lowering expensive drug costs.
With only two weeks left in the legislative session, a Democratic lawmaker and the state comptroller are feverishly working to bring to the House floor proposed legislation that is considered Connecticut’s most comprehensive effort so far to control high prescription drug costs.
Washington – A year after it was embroiled in scandal for jacking up the price of EpiPen injectors of a life saving anti-allergy medicine, the company that makes them is accused of overcharging state and federal governments, too, by $1.27 billion. Sen. Richard Blumenthal wants some of that money returned to Connecticut
WASHINGTON – Thousands of Connecticut residents will get rebate checks or other types of credit from their health insurance companies. They are getting those refunds because the federal government says they paid too much for coverage.